BCOR and TP53-Mutated Conventional and Dedifferentiated Chondrosarcoma: A Clinicopathologic Study

被引：0
|
作者：
Cerrillo, Diego Montoya [1 ]
Beshah, Fireneh [2 ]
Torres, Jaylou Velez [3 ]
Montgomery, Elizabeth [3 ]
Rosenberg, Andrew [2 ]
机构：
[1] Univ Miami Hosp, Jackson Mem Hosp, Miami, FL USA
[2] Univ Miami Hlth Syst, Miami, FL USA
[3] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
61
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [1] Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas
    Momeni-Boroujeni, Amir
    Dahoud, Wissam
    Vanderbilt, Chad M.
    Chiang, Sarah
    Murali, Rajmohan
    Rios-Doria, Eric, V
    Alektiar, Kaled M.
    Aghajanian, Carol
    Abu-Rustum, Nadeem R.
    Ladanyi, Marc
    Ellenson, Lora H.
    Weigelt, Britta
    Soslow, Robert A.
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2613 - 2623
  • [2] Decitabine in TP53-Mutated AML
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Garcia-Manero, Guillermo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 796 - 797
  • [3] Decitabine in TP53-Mutated AML Reply
    Welch, John S.
    Petti, Allegra A.
    Ley, Timothy J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 797 - 798
  • [4] Genomic landscape of TP53-mutated myeloid malignancies
    Abel, Haley J.
    Oetjen, Karolyn A.
    Miller, Christopher A.
    Ramakrishnan, Sai M.
    Day, Ryan B.
    Helton, Nichole M.
    Fronick, Catrina C.
    Fulton, Robert S.
    Heath, Sharon E.
    Tarnawsky, Stefan P.
    Srivatsan, Sridhar Nonavinkere
    Duncavage, Eric J.
    Schroeder, Molly C.
    Payton, Jacqueline E.
    Spencer, David H.
    Walter, Matthew J.
    Westervelt, Peter
    Dipersio, John F.
    Ley, Timothy J.
    Link, Daniel C.
    BLOOD ADVANCES, 2023, 7 (16) : 4586 - 4598
  • [5] TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [6] Candidate drug screening for TP53-mutated AML
    Gwak, Daehyeon
    Kim, Dong Chan
    Jang, Heejun
    Liu, Jun
    Byun, Ja Min
    Hong, Junshik
    Shin, Dong Yeop
    Yoon, Sung-Soo
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Revealing the dark secrets of TP53-mutated AML
    Hasserjian, Robert P.
    BLOOD, 2022, 140 (01) : 8 - 10
  • [8] Overall survival in TP53-mutated AML and MDS
    Christian J. Puzo
    Karl M. Hager
    Henry M. Rinder
    Olga K. Weinberg
    Alexa J. Siddon
    Annals of Hematology, 2024, 103 (12) : 5359 - 5369
  • [9] Characterization of Dysregulated Transcription in TP53-Mutated AML Subpopulations
    Issa, Ghayas C.
    Mohanty, Vakul
    Ayoub, Edward
    Wang, Feng
    Leighton, Jake
    Wu, Xiaogang
    Bidikian, Aram
    Patsilevas, Tallie
    Alaniz, Zoe
    Zarka, Jabra
    Kanagal-Shamanna, Rashmi
    Futreal, Andy
    Daver, Naval
    Konopleva, Marina
    Navin, Nicholas
    Zhang, Jianhua
    Chen, Ken
    Andreeff, Michael
    BLOOD, 2022, 140 : 6323 - 6325
  • [10] Reactivating hope for TP53-mutated acute myeloid leukaemia?
    Bug, Gesine
    LANCET HAEMATOLOGY, 2023, 10 (04): : E239 - E240
12345